$PDLI PDL BIOPHARMA, INC. Insider Trading Week 50/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PDL BIOPHARMA, INC. in week 50/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.61 | 398,000 | 1,038,780 | 15,261,460 | 14.9 M to 15.3 M (+2.68 %) |
| Dec 18 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.58 | 1,350,000 | 3,483,000 | 14,863,460 | 13.5 M to 14.9 M (+9.99 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Monnet Dominique | President and CEO | Sell | S | 2.60 | 500,000 | 1,300,000 | 734,921 | 1.2 M to 734.9 K (-40.49 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Monnet Dominique | President and CEO | Sell | S | 2.60 | 500,000 | 1,300,000 | 734,921 | 1.2 M to 734.9 K (-40.49 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
| Dec 15 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.59 | 1,000,000 | 2,590,000 | 13,513,460 | 12.5 M to 13.5 M (+7.99 %) |
| Dec 15 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.62 | 640,000 | 1,676,800 | 12,513,460 | 11.9 M to 12.5 M (+5.39 %) |
| Dec 15 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.45 | 450,000 | 1,102,500 | 11,873,460 | 11.4 M to 11.9 M (+3.94 %) |